Gilead Sciences Inc stock performance at a glance. Check Gilead Sciences Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value. GILD Stock Performance. USD USD; Previous close: Day range: - - Year range: 71 - 84 (%) Feb 29, , PM EST - Market open. Overview. Financials. Statistics. Forecast. Dividends. Profile. Company Description. Gilead Sciences, Inc., a Gilead Sciences. Sounds like they have a big Town hall tomorrow for the Biology group. Anyone know what they are going to announce? My guess is a reorg and
Gilead Sciences News | Interview, Salaries, and More - Blind
Stock Gilead Sciences, Inc. - Nasdaq. News Gilead Sciences, Inc. Transcript: Gilead Sciences, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference , Jan Best financial portal +% of historical performance More than 20 years at your side Overview. Gilead Sciences Inc. U.S.: Nasdaq. Add to Watchlist. About Gilead Sciences Inc. Gilead Sciences, Inc. is a biopharmaceutical company, which Gilead Sciences, Inc. (GILD) NasdaqGS - NasdaqGS Real-time price. Currency in USD. *Close price adjusted for splits. **Close price adjusted for splits and dividend and/or
Gilead Sciences, Inc. Stock price Santiago S.E. - MarketScreener.com
Job offer at gilead sciences - Blind. Industries. Job Groups. General Topics. Compensation Oct 18, AstraZeneca Linb Job offer at gilead sciences. Senior Company profile for Gilead Sciences, Inc. (GILD) with a description, list of executives, contact details and other key facts. Stock Analysis Pro. Watchlist. Collapse. Gilead Sciences, Inc. (GILD) NASDAQ: GILD · IEX Real-Time Price · USD. Add to Watchlist (%) By the numbers, Gilead Sciences stock rose 1,% between February and August , when it traded near all-time highs. Today, the healthcare giant is down about 41% FOSTER CITY, Calif (BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company’s Board of Directors has declared a cash dividend of $ per share of common stock for the second quarter of The dividend is payable on June 29, , to stockholders of record at As of December 31, , Gilead had $ billion of cash, cash equivalents and marketable debt securities compared to $ billion as of December 31, During the fourth quarter , Gilead generated $ billion in operating cash flow. During the fourth quarter , Gilead repaid $ billion in debt, paid cash dividends of US Pharmaceuticals. Summary. Quotes. Charts. News. Ratings. Calendar. Company. Financials. Consensus. Revisions. Financials (USD) More